Drug Profile
L 000124467
Alternative Names: L-000124467Latest Information Update: 10 May 2011
Price :
$50
*
At a glance
- Originator Merck & Co
- Class Antirheumatics; Neuropsychotherapeutics
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Multiple sclerosis; Rheumatoid arthritis